Reply to "Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome"
- PMID: 37088905
- DOI: 10.1097/TP.0000000000004611
Reply to "Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome"
Conflict of interest statement
J.C.G.-P. reports conflicts of interest with W.L. Gore and Associates, Cook Medical, Shionogi, and Vifor Pharma; grants from Conatus Pharmaceuticals and Theravance Biopharma; and grants from Novartis and Exalenz Bioscience, outside the submitted work. F.T. reports conflicts of interest with W.L. Gore and Associates, outside the submitted work. The other authors declare no conflicts of interest.
Comment on
-
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.Transplantation. 2023 Jun 1;107(6):1330-1340. doi: 10.1097/TP.0000000000004444. Epub 2023 May 23. Transplantation. 2023. PMID: 36479977
References
-
- Magaz M, Giudicelli-Lett H, Nicoară-Farcău O, et al. Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome. Transplantation. 2023;107:1330–1340.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical